Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Precision Medicine in Diabetes: A Consensus Report From the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Wendy K. Chung, Karel Erion, José C. Florez, et al.
Diabetes Care (2020) Vol. 43, Iss. 7, pp. 1617-1635
Open Access | Times Cited: 297

Showing 26-50 of 297 citing articles:

Person‐reported outcomes in diabetes care: What are they and why are they so important?
Norbert Hermanns, Bernhard Kulzer, Dominic Ehrmann
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. S1, pp. 30-45
Closed Access | Times Cited: 10
Furan-based chalcone protects β-cell damage and improves glucose uptake in alloxan-induced zebrafish diabetic model via influencing Peroxisome Proliferator-Activated Receptor agonists (PPAR-γ) signaling
S.P. Ramya Ranjan Nayak, B. Haridevamuthu, Raghul Murugan, et al.
Process Biochemistry (2024) Vol. 142, pp. 149-161
Closed Access | Times Cited: 10
Managing cardiovascular events, hyperglycemia, and obesity in type 2 diabetes through microRNA regulation linked to glucagon-like peptide-1 receptor agonists
Xiaolei Miao, Maryam Davoudi, Zahra Alitotonchi, et al.
Diabetology & Metabolic Syndrome (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 1
Diabetes in China: epidemiology, pathophysiology and multi-omics
Weiping Jia, Juliana C.N. Chan, Tien Yin Wong, et al.
Nature Metabolism (2025)
Closed Access | Times Cited: 1
Gene Therapy and Diabetes: A Narrative Review of Recent Advances and the Role of Multidisciplinary Healthcare Teams
Nadia Khartabil, Ani Avoundjian
Genes (2025) Vol. 16, Iss. 1, pp. 107-107
Open Access | Times Cited: 1
The Effect of HBV Therapy on Glycemic Control in HBV‐Infected Patients With Diabetes: A 90‐day Multicenter Study
Qi Liu, Jie Huang, Jingyi Hu, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 2
Closed Access | Times Cited: 1
Type 2 Diabetes Mellitus: A Comprehensive Review of Pathophysiology, Comorbidities, and Emerging Therapies
Aditi Singh, Sucharita Shadangi, Pulkit Kr. Gupta, et al.
Comprehensive physiology (2025) Vol. 15, Iss. 1
Closed Access | Times Cited: 1
Intralymphatic Glutamic Acid Decarboxylase With Vitamin D Supplementation in Recent-Onset Type 1 Diabetes: A Double-Blind, Randomized, Placebo-Controlled Phase IIb Trial
Johnny Ludvigsson, Zdenĕk Šumnı́k, Terezie Pelikánová, et al.
Diabetes Care (2021) Vol. 44, Iss. 7, pp. 1604-1612
Open Access | Times Cited: 45
Mutations and variants of ONECUT1 in diabetes
Anne Philippi, Sandra Heller, Ivan G. Costa, et al.
Nature Medicine (2021) Vol. 27, Iss. 11, pp. 1928-1940
Open Access | Times Cited: 41
Development of a treatment selection algorithm for SGLT2 and DPP-4 inhibitor therapies in people with type 2 diabetes: a retrospective cohort study
John Dennis, Katherine Young, Andrew McGovern, et al.
The Lancet Digital Health (2022) Vol. 4, Iss. 12, pp. e873-e883
Open Access | Times Cited: 32
Self-reported Severe and Nonsevere Hypoglycemia in Type 1 Diabetes: Population Surveillance Through the BETTER Patient Engagement Registry: Development and Baseline Characteristics
Anne‐Sophie Brazeau, Virginie Messier, Meryem K. Talbo, et al.
Canadian Journal of Diabetes (2022) Vol. 46, Iss. 8, pp. 813-821
Open Access | Times Cited: 31
Exploring the dual character of metformin in Alzheimer's disease
Pingping Ning, Anling Luo, Xin Mu, et al.
Neuropharmacology (2022) Vol. 207, pp. 108966-108966
Closed Access | Times Cited: 30
Artificial Intelligence Methodologies Applied to Technologies for Screening, Diagnosis and Care of the Diabetic Foot: A Narrative Review
Gaetano Chemello, Benedetta Salvatori, Micaela Morettini, et al.
Biosensors (2022) Vol. 12, Iss. 11, pp. 985-985
Open Access | Times Cited: 28
Precision medicine for cardiometabolic disease: a framework for clinical translation
Paul W. Franks, William T. Cefalu, John Dennis, et al.
The Lancet Diabetes & Endocrinology (2023) Vol. 11, Iss. 11, pp. 822-835
Closed Access | Times Cited: 21
Real-World Use of Once-Weekly Semaglutide in Type 2 Diabetes: Results from SemaglUtide Real-world Evidence (SURE) Germany
Markus Menzen, Tina Landsvig Berentzen, Andrei‐Mircea Catarig, et al.
Experimental and Clinical Endocrinology & Diabetes (2023) Vol. 131, Iss. 04, pp. 205-215
Open Access | Times Cited: 20
Antidiabetic Properties of Plant Secondary Metabolites
Станислав Сухих, Olga Babich, Alexander Prosekov, et al.
Metabolites (2023) Vol. 13, Iss. 4, pp. 513-513
Open Access | Times Cited: 17
Focus on the Most Common Paucisymptomatic Vasculopathic Population, from Diagnosis to Secondary Prevention of Complications
Eugenio Martelli, Iolanda Enea, Matilde Zamboni, et al.
(2023)
Open Access | Times Cited: 16
The use of precision diagnostics for monogenic diabetes: a systematic review and expert opinion
Rinki Murphy, Kevin Colclough, Toni I. Pollin, et al.
Communications Medicine (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 16
Atypical Diabetes: What Have We Learned and What Does the Future Hold?
Stephen Stone, Ashok Balasubramanyam, Jennifer E. Posey
Diabetes Care (2024) Vol. 47, Iss. 5, pp. 770-781
Open Access | Times Cited: 6
Pharmacogenomic Studies of Current Antidiabetic Agents and Potential New Drug Targets for Precision Medicine of Diabetes
Zhiwei Zeng, Shiying Huang, Tao Sun
Diabetes Therapy (2020) Vol. 11, Iss. 11, pp. 2521-2538
Open Access | Times Cited: 42
Parental Attitudes toward Artificial Intelligence-Driven Precision Medicine Technologies in Pediatric Healthcare
Bryan A. Sisk, Alison L. Antes, Sara Burrous, et al.
Children (2020) Vol. 7, Iss. 9, pp. 145-145
Open Access | Times Cited: 40
Comparison between data-driven clusters and models based on clinical features to predict outcomes in type 2 diabetes: nationwide observational study
Moa Lugner, Soffia Guðbjörnsdóttir, Naveed Sattar, et al.
Diabetologia (2021) Vol. 64, Iss. 9, pp. 1973-1981
Open Access | Times Cited: 34
Durable metabolic improvements 2 years after duodenal mucosal resurfacing (DMR) in patients with type 2 diabetes (REVITA-1 Study)
Annieke C.G. van Baar, Jacques Devière, David Hopkins, et al.
Diabetes Research and Clinical Practice (2022) Vol. 184, pp. 109194-109194
Open Access | Times Cited: 26
Spectrum of Phenotypes and Causes of Type 2 Diabetes in Children
Amy S. Shah, Kristen J. Nadeau, Dana Dabelea, et al.
Annual Review of Medicine (2022) Vol. 73, Iss. 1, pp. 501-515
Open Access | Times Cited: 26
Insulin: evolution of insulin formulations and their application in clinical practice over 100 years
Geremia B. Bolli, Alice Cheng, David R. Owens
Acta Diabetologica (2022) Vol. 59, Iss. 9, pp. 1129-1144
Open Access | Times Cited: 25

Scroll to top